Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Alzheimer's disease and herpes

Ruth F. Itzhaki and Curtis B. Dobson
CMAJ July 09, 2002 167 (1) 13;
Ruth F. Itzhaki
Molecular Neurobiology Laboratory, Department of Optometry & Neuroscience, University of Manchester Institute of Science & Technology, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis B. Dobson
Molecular Neurobiology Laboratory, Department of Optometry & Neuroscience, University of Manchester Institute of Science & Technology, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Herpes simplex virus type 1 (HSV1) is present in latent form in the brains of a high proportion of elderly people1 and is a risk factor for Alzheimer's disease in carriers of the type-4 allele of the apolipoprotein E gene (apoE-e4). ApoE-e4 is also a risk factor for cold sores.2,3 We have suggested that when HSV1 is reactivated in the nervous system the resulting damage is greater in apoE-e4 carriers than in people who carry the other apoE alleles. We recently detected antibodies to HSV1 in cerebrospinal fluid, substantiating our detection of HSV1 by polymerase chain reaction and showing that it does indeed reactivate (unpublished data). A clinical trial testing a synthetic amyloid peptide as immunotherapy for Alzheimer's disease was recently halted because 4 patients developed inflammation of the brain; in “some” of these 4 patients, a virus was detected in the cerebrospinal fluid.4

The results of René Verreault and colleagues5 raise the intriguing possibility that viruses other than HSV1 may directly influence Alzheimer's disease. Nonetheless, their findings could equally well be explained by an indirect effect: HSV1 reactivation can be triggered by inflammation, and vaccines would presumably prevent inflammation by preventing infection with the target virus, thus indirectly preventing HSV1 reactivation. Their study also supports the possibility that vaccination against HSV1 itself might prevent Alzheimer's disease; such vaccination is feasible now that the age at which primary infection occurs is rising. In fact, we have shown that vaccination of HSV1-infected mice with mixed HSV1 glycoproteins prevents establishment of latency in the brain.6

Finally, it would be interesting to know if the trend detected by Verreault and colleagues is dependent on the apoE-genotype. Such dependence has also been found for patients with herpes simplex encephalitis7 and for subjects infected with HIV but who have not yet developed AIDS.8

Ruth F. Itzhaki Curtis B. Dobson Molecular Neurobiology Laboratory Department of Optometry and Neuroscience University of Manchester Institute of Science and Technology Manchester, UK

References

  1. 1.↵
    Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF. Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol 1991;33:224-7.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997;349:241-4.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Lin WR, Graham J, MacGowan SM, Wilcock GK, Itzhaki RF. Alzheimer's disease, herpes virus in brain, apolipoprotein E4 and herpes labialis. Alzheimers Rep 1998;1:173-8.
    OpenUrl
  4. 4.↵
    Elan and AHP provide an update on the phase 2A clinical trial of AN-1792. Dublin: Elan Corporation; 2002. Available: www.elan.com/NewsRoom/NewsYear2002/01182002.asp?ComponentID=2330&Sour%20cePageID=2333#1 (accessed 2002 Mar 8).
  5. 5.↵
    Verreault R, Laurin D, Lindsay J, De Serres G. Past exposure to vaccines and subsequent risk of Alzheimer's disease. CMAJ 2001;165(11):1495-8.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Lin WR, Jennings R, Smith TL, Wozniak MA, Itzhaki RF. Vaccination prevents latent HSV1 infection of mouse brain. Neurobiol Aging 2001; 22: 699-703.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Lin WR, Wozniak MA, Esiri MM, Klenerman P, Itzhaki RF. Herpes simplex encephalitis: involvement of apolipoprotein E genotype. J Neurol Neurosurg Psychiatry 2001;70:117-9.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998;4:1182-4.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

CMAJ
Vol. 167, Issue 1
9 Jul 2002
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Alzheimer's disease and herpes
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Alzheimer's disease and herpes
Ruth F. Itzhaki, Curtis B. Dobson
CMAJ Jul 2002, 167 (1) 13;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Alzheimer's disease and herpes
Ruth F. Itzhaki, Curtis B. Dobson
CMAJ Jul 2002, 167 (1) 13;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Effective Treatment of Ocular HSK with a Human Apolipoprotein E Mimetic Peptide in a Mouse Eye Model
  • Google Scholar

More in this TOC Section

  • Study authors don’t consider waning SARS-CoV-2 immunity after vaccination in their model
  • The authors respond to criticisms of their model parameters
  • Error in key model input
Show more Letters

Similar Articles

Collections

  • Topics
    • Geriatric medicine
    • Infectious diseases
    • Neurology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire